Vitality Watch

⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

HD-tACS for Age-Related Visual Decline

Current understanding

High-definition transcranial alternating current stimulation (HD-tACS) with personalized complex waveforms is being tested as a way to restructure alpha-gamma phase-amplitude coupling (PAC) in visual cortex (V1) and area MT, on the hypothesis that disrupted PAC underlies age-related visual deficits [mechanism-plausible]. Two sham-controlled trials (n=120 each) are underway to test whether PAC can be causally driven into a preferred state and whether perception in older adults shifts bidirectionally as a result [human-rct, protocol-stage, no readout]. This sits apart from home tDCS: it targets oscillatory coupling rather than cortical excitability, and remains a research-lab intervention rather than a consumer trend.

Evidence log

  • 2026-07-23 — Memory Enhancement in Aging With Closed-Loop tACS: cross-connection with closed-loop-tacs-memory-aging: Both apply high-resolution tACS oscillatory entrainment to age-related decline in older adults, but target different circuits (memory networks vs V1/MT alpha-gamma coupling). (novelty: 3)
  • 2026-08-11 — Neuromodulation of Memory in Aging: cross-connection with tms-neuromodulation: Both are individualized, network/oscillation-guided non-invasive stimulation approaches for age-related cognitive/sensory decline, at protocol or proposal stage without outcome data. (novelty: 3)
  • 2026-07-16 — Restructuring the Alpha-Gamma Code in Aging Vision: cross-connection with tdcs-brain-stimulation: Both are non-invasive transcranial electrical stimulation for aging, but diverge on mechanism: tDCS shifts cortical excitability (cognition/mobility targets), HD-tACS entrains oscillatory coupling (sensory/perceptual targets). Useful contrast for readers conflating ‘brain stimulation’ as one category. (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials trial early
Restructuring the Alpha-Gamma Code in Aging Vision
16-jul-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18